No Data
No Data
Do Its Financials Have Any Role To Play In Driving Anhui Fengyuan Pharmaceutical Co., Ltd.'s (SZSE:000153) Stock Up Recently?
Fengyuan Pharmaceutical: 2024 Semi-Annual Report
Fengyuan Pharmaceutical: 2024 Semi-Annual Report Summary
Anhui Fengyuan Pharmaceutical (000153.SZ: net income of 0.1 billion yuan in the first half of the year, a year-on-year decrease of 2.72%
Anhui Fengyuan Pharmaceutical (000153.SZ) announced its half-yearly report for 2024 on August 28. During the reporting period, the total operating income was 2.308 billion yuan, a year-on-year increase of 0.98%; the net income attributable to shareholders of the listed company was 0.1 billion yuan, a year-on-year decrease of 2.72%; the net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 85.6384 million yuan, a year-on-year decrease of 2.71%; and the basic earnings per share was 0.2156 yuan.
As of August 10, 2024, Anhui Fengyuan Pharmaceutical (000153.SZ) had 39,562 shareholders.
Anhui Fengyuan Pharmaceutical (000153.SZ) stated on the investor interaction platform on August 13 that as of August 10, 2024, the company had 39,562 shareholders.
As of May 31, 2024, the number of shareholders of Anhui Fengyuan Pharmaceutical (000153.SZ) was 38,682.
Anhui Fengyuan Pharmaceutical (000153.SZ) stated on the investor interaction platform that as of May 31, 2024, the number of shareholders in the company was 38682.
No Data
No Data